Increased TGF‐β1‐mediated suppression of growth and motility in castrate‐resistant prostate cancer cells is consistent with Smad2/3 signaling
Authors:
- 6 January 2012
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 72 (12) , 1339-1350
Abstract
BACKGROUND: Elevated TGF‐β levels are associated with prostate cancer progression. Although TGF‐β is a tumor suppressor for normal epithelial and early‐stage cancer cells, it may act paradoxically as a tumor promoter in more advanced cancers, although its effects are largely cell and context dependent. This study analyzed prostate cancer responses to TGF‐β signaling in an isogenic model of androgen‐sensitive and castration‐resistant prostate cancer cells.METHODS: Phosphorylation and nuclear translocation of Smad2 and Smad3 were analyzed using immunoblotting. Proliferation and cell cycle responses to TGF‐β1 (5 ng/ml) were assessed using growth assays and flow cytometry for DNA content, as well as Western blot and immunoprecipitation of cell cycle proteins.RESULTS: Both androgen‐sensitive (LNCaP) and castration‐resistant (C4‐2 and C4‐2B) prostate cancer cell lines demonstrated TGF‐β1‐induced phosphorylation and nuclear translocation of Smad2/3 that was robust in metastatic lines. Smad phosphorylation was completely abrogated with inhibition of ALK‐5 kinase activity using the kinase inhibitor, SB‐431542. Increased sensitivity to TGF‐β1‐mediated growth inhibition was observed in C4‐2 and C4‐2B cells, as compared to LNCaP cells. This was paralleled with downregulation of Cyclin D and increased association of p15Ink4b or p27Kip with CDK's. Additionally, TGF‐β1 inhibited motility and invasion of metastatic cell lines.CONCLUSIONS: TGF‐β‐mediated suppression of growth and motility is enhanced in metastatic, castration‐resistant prostate cancer cells. Enhanced TGF‐β1‐induced Smad2 and ‐3 signaling in prostate cancer cells may correlate with tumor suppressive activity. Therefore, the direct effects of TGF‐β1 on prostate cancer cells post‐castration may be anti‐tumorigenic and growth‐suppressive. Prostate 72:1339–1350, 2012.Keywords
This publication has 34 references indexed in Scilit:
- Androgenic Control of Transforming Growth Factor-β Signaling in Prostate Epithelial Cells through Transcriptional Suppression of Transforming Growth Factor-β Receptor IICancer Research, 2008
- Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axisOncogene, 2008
- Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF‐αJournal of Cellular Biochemistry, 2008
- TGFβ in CancerCell, 2008
- The logic of TGFβ signalingFEBS Letters, 2006
- Blockade of Transforming Growth Factor-β Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude MiceClinical Cancer Research, 2005
- TGF-β signaling: positive and negative effects on tumorigenesisCurrent Opinion in Genetics & Development, 2002
- LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasisThe Prostate, 2000
- Insensitivity to growth inhibition by TGF-β1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cellsOncogene, 1998
- Localization of Transforming Growth Factor-β1 and Type II Receptor in Developing Normal Human Prostate and Carcinoma TissuesJournal of Histochemistry & Cytochemistry, 1998